Why the study?
What are the screening methods, diagnostic techniques, and pharmacologic/nonpharmacologic means of preventing VTE in patients with hemorrhagic stroke?
What are the screening methods, diagnostic techniques, and pharmacologic/nonpharmacologic means of preventing VTE in patients with hemorrhagic stroke?
This review summarizes screening, diagnosis, and prevention strategies for venous thromboembolism in patients with hemorrhagic stroke.
Consolidates VTE strategies for hemorrhagic stroke; leaves open need for RCTs to define optimal prevention.
Deep venous thrombosis (DVT) and pulmonary embolism (PE) are part of the spectrum of venous thromboembolism (VTE). It is one of the most frequent medical complications in stroke patients. The risk of VTE is even higher after hemorrhagic stroke. This article reviews various screening methods, diagnostic techniques, and pharmacologic as well as nonpharmacologic means of preventing VTE after hemorrhagic stroke.
No takes yet. Share an insight, caveat, or question.
Chaudhry et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: